End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.95 TWD | +3.17% | +6.17% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ling Mei Wang
CEO | Chief Executive Officer | - | 18-11-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Hung Yeh
BRD | Director/Board Member | 52 | 21-12-07 |
Cheng Chi Chiang
BRD | Director/Board Member | - | 20-09-14 |
Ling Mei Wang
CEO | Chief Executive Officer | - | 18-11-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,795,094 | 47,420,250 ( 84.99 %) | 0 | 84.99 % |
Company contact information
Steminent Biotherapeutics, Inc.
16 Wenhu Street Neihu District
114006, Taipei
+
http://www.steminent.comSector
1st Jan change | Capi. | |
---|---|---|
-.--% | 51.68M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- 7729 Stock
- Company Steminent Biotherapeutics, Inc